Malignant salivary gland tumors are rare. The most common tumor site is the parotid.
Aetiologic factors are not clear. Nutrition may be a risk factor, as well as irradiation or a long …

Adenoid cystic carcinomas (ACC) are rare cancers usually arising in the salivary glands.
Once metastatic, the natural history can vary; some patients with indolent cancer remain …

PURPOSE To provide evidence-based recommendations for practicing physicians and
other healthcare providers on the management of salivary gland malignancy. METHODS …

Safety and Efficacy of Nivolumab Monotherapy in Recurrent or Metastatic Cervical, Vaginal,
or Vulvar Carcinoma: Results From the Phase I/II CheckMate 358 Trial - PMC Back to Top …

Pembrolizumab for the Treatment of Advanced Salivary Gland C... : American Journal of
Clinical Oncology Pembrolizumab for the Treatment of Advanced Salivary Gland Carcinoma …

Background There is no standard first-line chemotherapy for recurrent/metastatic (RM) or
unresectable locally advanced (LA) salivary gland carcinoma (SGC). Patients and methods …

Adenoid cystic carcinoma (ACC) is a rare malignant tumor derived mainly from the salivary
glands, representing approximately 1% of all head and neck carcinomas and 10% of all …

Salivary duct carcinoma (SDC) is an aggressive subtype of primary salivary gland
carcinoma, often with an advanced stage at presentation and high rates of metastasis and …

Adenoid cystic carcinoma (ACC) is a slow growing, but relentless cancer. Due to its rarity
and lack of understanding of its molecular etiology, no standard chemotherapy for ACC …

Salivary gland cancers are rare with an annual incidence of approximately 3.0 cases per
100,000 in the United States accounting for less than 3% of all head and neck cancers. They …